The Toronto-Dominion Bank Acquires 5.5% Stake in Immatics N.V. (IMTX)

On May 15, 2026, The Toronto-Dominion Bank filed a Schedule 13G with the SEC, reporting a new ownership stake in Immatics N.V. (IMTX). As of the event date on March 31, 2026, the filer beneficially owns 7,436,342 ordinary shares, representing 5.5% of the company's total shares outstanding. This acquisition marks a significant increase from a previous position of zero shares. The filing indicates that The Toronto-Dominion Bank holds sole voting and dispositive power over all 7,436,342 shares. The shares were acquired in the ordinary course of business and are not held for the purpose of changing or influencing the control of the issuer. The Toronto-Dominion Bank is classified as a foreign institution (Bank) based in Canada. This move establishes a substantial minority position for the bank in the biopharmaceutical company, which specializes in T-cell redirecting cancer immunotherapies.